Free Trial

This company has been marked as potentially delisted and may not be actively trading.

ImmunoGen (IMGN) News Today

ImmunoGen logo

IMGN Latest News

Artisan International Small-Mid Instl
Artisan International Small-Mid Advisor
Polaris Global Equity Composite Q1 2024 Commentary
3 Potential Biopharma Buyout Targets
CERE Aug 2024 30.000 call
Barclays Keeps Their Hold Rating on ImmunoGen (IMGN)
ImmunoGen (Nasdaq:IMGN) Headline
Trading was temporarily halted for "IMGN" at 07:02 PM with a stated reason of "News pending."...
How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry
IMGN Quantitative Stock Analysis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EAR, IMGN, CVLY
Immunogen Inc IMGN
Abbvie stock dividend
AbbVie continues shopping spree with biotech buyout (IMGN)
While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend.
AbbVie acquiring Cerevel Therapeutics in $8.7B deal
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
Barclays Downgrades Immunogen (IMGN)
Guggenheim Downgrades Immunogen (IMGN)
Maintaining Hold on ImmunoGen Amid AbbVie Acquisition Offer
ImmunoGen downgraded to Hold from Buy at Canaccord
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
Get ImmunoGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMGN and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMGN Media Mentions By Week

IMGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMGN
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

IMGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMGN Articles
This Week

0

0

IMGN Articles
Average Week

Get the Latest News and Ratings for IMGN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for ImmunoGen and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:IMGN) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners